Horizon Therapeutics Public Limited Company (HZNP)

Growth

Revenue 5Y20.97%
Revenue 3Y29.59%
EPS 5Y35.24%
EPS 3Y98.90%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC8.28%
ROE11.80%
ROA6.36%
ROTA10.52%

Capital Structure

Market Cap25.27B
EV25.70B
Cash2.13B
Current Ratio3.96
Debt/Equity0.44
Net Debt/EBITDA0.41
Show More

Income Statement

Select a metric from the list below to chart it

Dec '08
Dec '11
Dec '14
Dec '17
Dec '20
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
74.0
297.0
757.0
981.1
1,056.2
1,207.6
1,300.0
2,200.4
3,226.4
3,701.5
Revenue % Chg.
277.0%
301.2%
154.9%
29.6%
7.7%
14.3%
7.7%
69.3%
46.6%
25.2%
Cost of Revenue
14.6
78.8
219.5
393.3
546.3
422.3
362.2
532.7
794.5
920.9
Cost of Revenue % Chg.
15.5%
438.5%
178.7%
79.2%
38.9%
-22.7%
-14.2%
47.1%
49.1%
28.7%
Gross Profit
59.4
218.2
537.5
587.8
510.0
785.3
937.9
1,667.7
2,431.9
2,780.6
Gross Profit % Chg.
752.2%
267.4%
146.4%
9.4%
-13.3%
54.0%
19.4%
77.8%
45.8%
24.0%
Gross Profit Margin
80.2%
73.5%
71.0%
59.9%
48.3%
65.0%
72.1%
75.8%
75.4%
75.1%
Gross Profit Margin % Chg.
126.0%
-8.4%
-3.4%
-15.6%
-19.4%
34.7%
10.9%
5.1%
-0.5%
-0.9%
R&D Expenses
10.1
17.5
41.9
60.7
225.0
82.8
103.2
209.4
432.0
461.4
R&D Expenses % Chg.
-40.1%
73.1%
139.8%
45.0%
270.6%
-63.2%
24.7%
102.9%
106.3%
27.5%
Selling, General, & Admin Expenses
92.2
209.2
440.3
608.3
677.4
692.5
697.1
973.2
1,446.4
1,586.5
Selling, General, & Admin Expenses % Chg.
33.6%
127.0%
110.4%
38.2%
11.4%
2.2%
0.7%
39.6%
48.6%
19.8%
Operating Income
-42.9
-8.5
55.4
-147.2
-392.4
2.4
126.6
490.0
543.1
676.6
Operating Income % Chg.
45.7%
80.2%
-
-
166.6%
-
5193.1%
287.0%
10.8%
23.0%
Operating Income Margin
-57.9%
-2.9%
7.3%
-15.0%
-37.1%
0.2%
9.7%
22.3%
16.8%
18.3%
Operating Income Margin % Chg.
85.6%
95.1%
-
-
147.7%
-
4816.7%
128.7%
-24.4%
-1.7%
Total Other Income/Expenses Net
-107.3
-261.2
-188.1
-80.9
-120.9
-121.5
-146.8
-88.4
-80.3
-92.9
Total Other Income/Expenses Net % Chg.
661.2%
143.5%
28.0%
57.0%
49.4%
0.5%
20.8%
39.8%
9.1%
35.1%
Income Before Tax
-150.1
-269.7
-132.7
-228.1
-513.3
-119.1
-20.2
401.6
462.8
583.7
Income Before Tax % Chg.
61.5%
79.6%
50.8%
71.9%
125.0%
76.8%
83.0%
-
15.2%
21.3%
Income Before Tax Margin
-202.8%
-90.8%
-17.5%
-23.2%
-48.6%
-9.9%
-1.6%
18.3%
14.3%
15.8%
Income Before Tax Margin % Chg.
57.2%
55.2%
80.7%
32.6%
109.0%
79.7%
84.2%
-
-21.4%
-3.1%
Income Tax Expense
-1.1
-6.1
-172.2
-61.3
-102.7
-45.0
-593.2
11.8
-71.7
9.4
Income Tax Expense % Chg.
78.3%
442.7%
2731.1%
64.4%
67.8%
56.2%
1219.5%
-
-
-
Net Income
-149.0
-263.6
39.5
-166.8
-410.5
-74.2
573.0
389.8
534.5
574.3
Net Income % Chg.
69.7%
76.9%
-
-
146.1%
81.9%
-
-32.0%
37.1%
4.1%
Net Income Margin
-201.3%
-88.8%
5.2%
-17.0%
-38.9%
-6.1%
44.1%
17.7%
16.6%
15.5%
Net Income Margin % Chg.
55.0%
55.9%
-
-
128.6%
84.2%
-
-59.8%
-6.5%
-16.9%
Weighted Avg. Shares Out
63.7
83.8
148.8
160.7
163.1
166.2
182.9
204.0
204.0
229.1
Weighted Avg. Shares Out % Chg.
63.8%
31.6%
77.7%
8.0%
1.5%
1.9%
10.1%
11.5%
-
2.3%
EPS
-2.3
-3.2
0.3
-1.0
-2.5
-0.5
3.1
1.9
2.4
2.5
EPS % Chg.
3.5%
34.6%
-
-
142.3%
82.1%
-
-39.0%
24.1%
2.4%
Weighted Avg. Shares Out Dil
63.7
83.8
155.9
160.7
163.1
166.2
205.2
215.3
215.3
236.1
Weighted Avg. Shares Out Dil % Chg.
63.8%
31.6%
86.2%
3.1%
1.5%
1.9%
23.5%
4.9%
-
1.7%
EPS Diluted
-2.3
-3.2
0.3
-1.0
-2.5
-0.5
2.9
1.8
2.3
2.4
EPS Diluted % Chg.
3.5%
34.6%
-
-
142.3%
82.1%
-
-37.6%
25.4%
5.2%
Interest Expense
39.2
23.8
69.9
86.6
126.5
121.7
87.1
59.6
81.1
87.2
Interest Expense % Chg.
169.7%
-39.2%
193.4%
23.9%
46.1%
-3.8%
-28.4%
-31.5%
36.0%
23.6%
EBIT
-189.3
-293.5
-202.6
-314.7
-639.8
-240.8
-107.3
342.0
381.8
496.5
EBIT % Chg.
76.1%
55.0%
31.0%
55.3%
103.3%
62.4%
55.4%
-
11.6%
20.9%
EBIT Margin
-255.8%
-98.8%
-26.8%
-32.1%
-60.6%
-19.9%
-8.3%
15.5%
11.8%
13.4%
EBIT Margin % Chg.
53.3%
61.4%
72.9%
19.8%
88.8%
67.1%
58.6%
-
-23.9%
-3.4%
Depreciation & Amortization
9.3
34.0
138.3
221.8
283.4
275.7
237.2
279.5
353.8
388.2
Depreciation & Amortization % Chg.
68.1%
265.3%
306.8%
60.4%
27.8%
-2.7%
-14.0%
17.8%
26.6%
18.8%
EBITDA
-180.0
-259.5
-64.3
-92.9
-356.4
34.9
129.8
621.5
735.5
884.6
EBITDA % Chg.
76.5%
44.2%
75.2%
44.5%
283.8%
-
272.1%
378.6%
18.3%
19.9%
EBITDA Margin
-243.2%
-87.4%
-8.5%
-9.5%
-33.7%
2.9%
10.0%
28.2%
22.8%
23.9%
EBITDA Margin % Chg.
53.2%
64.1%
90.3%
11.5%
256.5%
-
245.7%
182.8%
-19.3%
-4.2%